Positron Emission Tomography Computed Tomography
-
Subject Areas on Research
-
18F-FDG PET/CT Metabolic Tumor Volume and Intratumoral Heterogeneity in Pancreatic Adenocarcinomas: Impact of Dual-Time Point and Segmentation Methods.
-
18F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus-Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified Therapy: Results from NRG-HN002.
-
18F-FDG PET/CT Staging of Head and Neck Cancer: Interobserver Agreement and Accuracy-Results from Multicenter ACRIN 6685 Clinical Trial.
-
18F-FDG PET/CT and Melanoma: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management.
-
18F-FDG PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients.
-
18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies.
-
18F-fluciclovine PET/CT detection of biochemical recurrent prostate cancer in patients with PSA levels <2.00 ng/mL.
-
2-Deoxy-2-[18F] Fluoro-d-Glucose PET/Computed Tomography: Therapy Response Assessment in Head and Neck Cancer.
-
64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer.
-
68Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer.
-
68Ga-DOTATATE: Significance of Uptake in the Tail of the Pancreas in Patients Without Lesions.
-
68Ga-PSMA PET/CT and PET/MRI in high-risk prostate cancer patients.
-
ACR Appropriateness Criteria® Acute Respiratory Illness in Immunocompromised Patients.
-
ACR Appropriateness Criteria® Palpable Abdominal Mass-Suspected Neoplasm.
-
ACR Appropriateness Criteria® Plexopathy.
-
ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer.
-
ACR Appropriateness Criteria® Pretreatment Detection, Surveillance, and Staging of Prostate Cancer: 2022 Update.
-
ACR Appropriateness Criteria® Primary Bone Tumors.
-
ACR Appropriateness Criteria® Staging and Follow-Up of Esophageal Cancer.
-
ACR Appropriateness Criteria® Suspected Pulmonary Hypertension.
-
ACR Practice Parameter for the Performance of Gallium-68 DOTATATE PET/CT for Neuroendocrine Tumors.
-
ACR-ACNM Practice Parameter for the Performance of Fluorine-18 Fluciclovine-PET/CT for Recurrent Prostate Cancer.
-
ACR-SPR-STR Practice Parameter for the Performance of Cardiac Positron Emission Tomography - Computed Tomography (PET/CT) Imaging.
-
Adapting a Standardized, Industry-Proven Tool to Measure Patients' Perceptions of Quality at the Point of Care in a PET/CT Center.
-
Advances in Lung Cancer Imaging.
-
An Adipose Tissue Atlas: An Image-Guided Identification of Human-like BAT and Beige Depots in Rodents.
-
Apolipoprotein E Mimetic Peptide Increases Cerebral Glucose Uptake by Reducing Blood-Brain Barrier Disruption after Controlled Cortical Impact in Mice: An 18F-Fluorodeoxyglucose PET/CT Study.
-
Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease.
-
Association Between Aortic Vascular Inflammation and Coronary Artery Plaque Characteristics in Psoriasis.
-
Association Between Skin and Aortic Vascular Inflammation in Patients With Psoriasis: A Case-Cohort Study Using Positron Emission Tomography/Computed Tomography.
-
Association of Interim FDG-PET Imaging During Chemoradiation for Squamous Anal Canal Carcinoma With Recurrence.
-
CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET.
-
Cardiovascular Imaging With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Patients With Fibroinflammatory Disorders.
-
Case 260: Endobronchial Posttransplantation Lymphoproliferative Disease.
-
Changes on Midchemoradiation Therapy Fluorodeoxyglucose Positron Emission Tomography for Cervical Cancer Are Associated with Prognosis.
-
Clinical Indications and Impact on Management: Fourth and Subsequent Posttherapy Follow-up 18F-FDG PET/CT Scans in Oncology Patients.
-
Clinical Practice in PET/CT for the Management of Head and Neck Squamous Cell Cancer.
-
Clinical and Technical Considerations for Brain PET Imaging for Dementia.
-
Comparative effectiveness: 18F-FDG-PET/CT versus CT for post-treatment follow-up of patients with lung cancer.
-
Comparison of Bayesian penalized likelihood reconstruction versus OS-EM for characterization of small pulmonary nodules in oncologic PET/CT.
-
Consolidation Radiation Therapy for Patients With Advanced Hodgkin Lymphoma in Complete Metabolic Response According to PET-CT or Gallium Imaging.
-
Diagnostic Evaluation of Chronic Thromboembolic Pulmonary Hypertension.
-
Diffusion-weighted MR in chronic periaortitis, a new technique has entered the clinical arena.
-
Divergent Interpretations of Imaging After Stereotactic Body Radiation Therapy for Lung Cancer.
-
Does Routine Posttreatment PET/CT Add Value to the Care of Women With Locally Advanced Cervical Cancer?
-
Dual Somatostatin Receptor/FDG PET/CT Imaging in Metastatic Neuroendocrine Tumours: Proposal for a Novel Grading Scheme with Prognostic Significance.
-
Dual-Energy CT Vital Iodine Tumor Burden for Response Assessment in Patients With Metastatic GIST Undergoing TKI Therapy: Comparison With Standard CT and FDG PET/CT Criteria.
-
Dynamic prognostication using conditional survival analysis for patients with operable lung adenocarcinoma.
-
Early 18F-FDG-PET Response During Radiation Therapy for HPV-Related Oropharyngeal Cancer May Predict Disease Recurrence.
-
Effect of Immunosuppressive Therapy and Biopsy Status in Monitoring Therapy Response in Suspected Cardiac Sarcoidosis.
-
Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction.
-
Executive summary of AAPM Report Task Group 113: Guidance for the physics aspects of clinical trials.
-
FDG PET/CT for Primary Staging of Lung Cancer and Mesothelioma.
-
FDG-PET/CT and MRI for Evaluation of Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer: A Meta-Analysis of Diagnostic Accuracy Studies.
-
FDG-PET/CT and Pathology in Newly Diagnosed Head and Neck Cancer: ACRIN 6685 Trial, FDG-PET/CT cN0.
-
Fluorine-18 labeling of an anti-HER2 VHH using a residualizing prosthetic group via a strain-promoted click reaction: Chemistry and preliminary evaluation.
-
Fluorine-18-Labeled Fluciclovine PET/CT in Primary and Biochemical Recurrent Prostate Cancer Management.
-
Ga-68 DOTATATE PET/CT and F-18 FDG PET/CT in the evaluation of low and intermediate versus high-grade neuroendocrine tumors.
-
Gastroenteropancreatic Neuroendocrine Tumor Diagnosis: DOTATATE PET/CT.
-
Head and Neck Cancer and PET/Computed Tomography.
-
Higher BMI, But Not Sarcopenia, Is Associated With Pembrolizumab-related Toxicity in Patients With Advanced Melanoma.
-
IV Contrast Material for PET/CT: Point-Putting the CT Into PET/CT.
-
Impact of Neck PET/CT Positivity on Survival Outcomes-Visual and Quantitative Assessment: Results From ACRIN 6685.
-
Impact of Point-Spread Function Reconstruction on 68Ga-DOTATATE PET/CT Quantitative Imaging Parameters.
-
Improving the rates of Aspergillus detection: an update on current diagnostic strategies.
-
Incidental Detection of Metastatic Penile Squamous-Cell Carcinoma With Anti-1-Amino-3-F-18-Fluorocyclobutane-1-Carboxylic Acid (18F-Fluciclovine) PET/CT in a Patient With Recurrent Prostate Cancer.
-
Inhibition of Blood-Brain Barrier Disruption by an Apolipoprotein E-Mimetic Peptide Ameliorates Early Brain Injury in Experimental Subarachnoid Hemorrhage.
-
Intratreatment Response Assessment With 18F-FDG PET: Correlation of Semiquantitative PET Features With Pathologic Response of Esophageal Cancer to Neoadjuvant Chemoradiotherapy.
-
Intratumoral Metabolic Heterogeneity and Other Quantitative 18F-FDG PET/CT Parameters for Prognosis Prediction in Esophageal Cancer.
-
Intrinsic radiomic expression patterns after 20 Gy demonstrate early metabolic response of oropharyngeal cancers.
-
Invasive Mediastinal Staging for Lung Cancer by The Society of Thoracic Surgeons Database Participants.
-
Isolated recto-sigmoid colitis: a new imaging pattern of ipilimumab-associated colitis.
-
JOURNAL CLUB: Value of Quantitative FDG PET/CT Volumetric Biomarkers in Recurrent Colorectal Cancer Patient Survival.
-
Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring.
-
Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring.
-
Labeling a TCO-functionalized single domain antibody fragment with 18F via inverse electron demand Diels Alder cycloaddition using a fluoronicotinyl moiety-bearing tetrazine derivative.
-
Low contralateral neck recurrence risk with ipsilateral neck radiotherapy in N2b tonsillar squamous cell carcinoma.
-
Lung Cancer Recurrence: 18F-FDG PET/CT in Clinical Practice.
-
Mechanism-Specific Pharmacodynamics of a Novel Complex-I Inhibitor Quantified by Imaging Reversal of Consumptive Hypoxia with [18F]FAZA PET In Vivo.
-
Molecular Imaging and Precision Medicine in Head and Neck Cancer.
-
Molecular Imaging and Precision Medicine: PET/Computed Tomography and Therapy Response Assessment in Oncology.
-
Molecular Imaging and Therapy for Neuroendocrine Tumors.
-
Multicenter Trial of [18F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685.
-
Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.
-
NCCN Guidelines Insights: Bone Cancer, Version 2.2017.
-
Neuroendocrine Tumor Diagnosis and Management: 68Ga-DOTATATE PET/CT.
-
Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus.
-
Non-invasive sensitive brain tumor detection using dual-modality bioimaging nanoprobe.
-
Outcomes and Predictive Value of Post-adjuvant Therapy PET/CT for Locally Advanced Oral Squamous Cell Carcinoma.
-
PET Imaging for Head and Neck Cancers.
-
PET Imaging of Oral Cavity and Oropharyngeal Cancers.
-
PET-Computed Tomography and Precision Medicine in Pancreatic Adenocarcinoma and Pancreatic Neuroendocrine Tumors.
-
PET-detected asymptomatic recurrence is associated with improved survival in recurrent cervical cancer.
-
PET/CT of Dementia.
-
PET/Computed Tomography Scanning and Precision Medicine: Esophageal Cancer.
-
PET/Computed Tomography and Precision Medicine: Gastric Cancer.
-
PET/Computed Tomography and Precision Medicine: Musculoskeletal Sarcoma.
-
PET/Computed Tomography: Post-therapy Follow-up in Head and Neck Cancer.
-
Phase 2 Study of Dose-Reduced Consolidation Radiation Therapy in Diffuse Large B-Cell Lymphoma.
-
Positron Emission Tomography-Computed Tomography Imaging of Selective Lobar Delivery of Stem Cells in Ex Vivo Lung Model of Mechanical Ventilation.
-
Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study.
-
Practical Considerations for Integrating PET/CT into Radiation Therapy Planning.
-
Precision Medicine and PET-Computed Tomography in Pediatric Malignancies.
-
Precision Medicine and PET/Computed Tomography in Melanoma.
-
Precision Medicine and PET/Computed Tomography: Challenges and Implementation.
-
Precision Medicine and PET/Computed Tomography: Time Has Arrived.
-
Preclinical Evaluation of 18F-Labeled Anti-HER2 Nanobody Conjugates for Imaging HER2 Receptor Expression by Immuno-PET.
-
Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET/CT.
-
Predictive value of initial imaging and staging with long-term outcomes in young adults diagnosed with colorectal cancer.
-
Pretreatment 18F-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Values and Tumor Size in Medically Inoperable Nonsmall Cell Lung Cancer Is Prognostic of Overall 2-Year Survival After Stereotactic Body Radiation Therapy.
-
Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features.
-
Pulmonary Valve Endocarditis: The Potential Utility of Multimodal Imaging Prior to Surgery.
-
Pulmonary blastomycosis presenting as primary lung cancer.
-
Quality Improvement Initiatives to Assess and Improve PET/CT Injection Infiltration Rates at Multiple Centers.
-
Quantitative PET/CT in clinical practice: assessing the agreement of PET tumor indices using different clinical reading platforms.
-
Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer/T-cell lymphoma, nasal type: a multicentre, retrospective analysis.
-
Rituximab monotherapy to treat intravascular large B-cell lymphoma manifesting as pruritic calf patch in an elderly female.
-
Role of 18 F-FDG PET/CT differentiating olfactory neuroblastoma from sinonasal undifferentiated carcinoma.
-
Role of 18F-Fluciclovine and Prostate-Specific Membrane Antigen PET/CT in Guiding Management of Oligometastatic Prostate Cancer: AJR Expert Panel Narrative Review.
-
Role of FDG PET/CT in the Eighth Edition of TNM Staging of Non-Small Cell Lung Cancer.
-
Role of Non-FDG-PET/CT in Head and Neck Cancer.
-
Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin.
-
Role of salvage lymph node dissection in prostate cancer.
-
SNMMI Comment on the 2016 Society of Surgical Oncology "Choosing Wisely" Recommendation on the Use of PET/CT in Colorectal Cancer.
-
Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors.
-
Section Editor's Notebook: Prostate Cancer Theranosis in Clinical Practice and in Clinical Trials-68Ga-Prostate-Specific Member Antigen (PSMA)-11 PET/CT and 177Lu-PSMA-617 Therapy.
-
Self-reported depression in psoriasis is associated with subclinical vascular diseases.
-
Site-Specific and Residualizing Linker for 18F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment.
-
Skeletal Metastasis Evaluation: Value and Impact of PET/Computed Tomography on Diagnosis, Management and Prognosis.
-
Stage I-II nodular lymphocyte-predominant Hodgkin lymphoma: a multi-institutional study of adult patients by ILROG.
-
Stereotactic Body Radiation Therapy-Induced Abscopal Effect on Hepatocellular Carcinoma After Treatment for Lung Cancer: A Case Report.
-
Surveillance imaging in mantle cell lymphoma in first remission lacks clinical utility.
-
Surveillance strategies in the follow-up of melanoma patients: too much or not enough?
-
Synthesis and Preliminary Evaluation of 5-[18F]fluoroleucine.
-
Targeting MET Amplification with Crizotinib in a Case of Sinonasal Undifferentiated Carcinoma.
-
The QIBA Profile for FDG PET/CT as an Imaging Biomarker Measuring Response to Cancer Therapy.
-
The Value of FDG PET/CT in Treatment Response Assessment, Follow-Up, and Surveillance of Lung Cancer.
-
The cumulative radiation dose paradigm in pediatric imaging.
-
The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events.
-
The utility of initial staging PET-CT as a baseline scan for surveillance imaging in stage II and III melanoma.
-
The value of follow-up FDG-PET/CT in the management and prognosis of patients with HPV-positive oropharyngeal squamous cell carcinoma.
-
Treatment of Thymoma-Associated Myasthenia Gravis With Stereotactic Body Radiotherapy: A Case Report.
-
Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer.
-
Update on pediatric rhabdomyosarcoma: A report from the APSA Cancer Committee.
-
Use of peripheral arterial tonometry in detection of abnormal coronary flow reserve.
-
Utility of discovery approach using proteomics to create a biomarker profile for coronary microvascular dysfunction.
-
Value of Intratumoral Metabolic Heterogeneity and Quantitative 18F-FDG PET/CT Parameters in Predicting Prognosis for Patients With Cervical Cancer.
-
Value of Intratumoral Metabolic Heterogeneity and Quantitative 18F-FDG PET/CT Parameters to Predict Prognosis in Patients With HPV-Positive Primary Oropharyngeal Squamous Cell Carcinoma.
-
Value of fourth and subsequent post-therapy follow-up 18F-FDG PET/CT scans in patients with breast cancer.
-
Visual and semiquantitative analysis of 82Rb uptake in malignant tumors on PET/CT: first systematic analysis.
-
[18
F]Fluoro-DCP, a first generation PET radiotracer for monitoring protein sulfenylation in vivo.